Investing Profile

David Ebsworth

InvestorAngel
Chairman Of The Supervisory Board at Synlab AG
Photo of David Ebsworth, Angel
cb
Angel
$5K - $50K
$25K
2
CompanyStageDateRound SizeTotal Raised
Verona Pharma
Post Ipo EquityJul 2020$200M
$200M
Small Pharma
SeedApr 2017$1M
$1M
£830K
Co-investors: Ken Belotsky (Negev Capital), Peter Keen